Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 12 Lung Neoplasms 9 Carcinoma, Hepatocellular 9 Small Cell Lung Carcinoma 8 Breast Neoplasms 6 Urinary Bladder Neoplasms 5 Triple Negative Breast Neoplasms 5 Neoplasms 5 Neoplasm Metastasis 5 Melanoma 5 Glioblastoma 5 Carcinoma, Transitional Cell 5 Ovarian Neoplasms 4 Advanced Solid Tumor 4 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Sarcoma 3 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Follicular 3 Liver Neoplasms 3 Esophageal Neoplasms 3 Carcinoma, Renal Cell 3 Carcinoma, Neuroendocrine 3 Solid Cancer 2 Small Cell Lung Cancer Extensive Stage 2 Recurrence 2 Neuroendocrine Tumors 2 Lymphoma, Large B-Cell, Diffuse 2

Interventions

tocilizumab 1 atezolizumab 1 Tiragolumab 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Advanced Liver Cancers × atezolizumab × Clear all

NCT04524871 2026-05-22

MORPHEUS-LIVER

Hoffmann-La Roche

Phase 1/2 Recruiting

Advanced Liver Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡